Form C-AR — 20/20 Biolabs, Inc.
0001213900-23-034677 · filed May 1, 2023
https://biolabs.io
(possible website — auto-inferred, not verified)
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1139685
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, MD 20877 - Phone
- —
Most recent fiscal year financials
- Total assets
- $12,215,021
- Cash
- —
- Short-term debt
- —
- Long-term debt
- $207,246
- Revenues
- $11,059,145
- COGS
- $5,937,398
- Taxes paid
- —
- Net income
- $2,186,875
Same issuer's Form D filings
-
D · Feb 26, 2025$3M
View the original filing on SEC EDGAR ↗